51 – 60 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour
- Contribution to journal › Article
-
Mark
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
- Contribution to journal › Article
-
Mark
Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer.
(2020) The Society for Immunotherapy of Cancer's (SITC) 35th annual meeting In Journal for ImmunoTherapy of Cancer 8(Suppl. 3).
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Disseqt-distribution-based modeling of sequence space time dynamics
- Contribution to journal › Article
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
- Contribution to journal › Article
-
Mark
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
- Contribution to journal › Article
-
Mark
PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia
- Contribution to journal › Article
-
Mark
Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin
- Contribution to journal › Article
-
Mark
Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
FLT3
N676K
drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
- Contribution to journal › Letter
